Marshall Wace, LLP Ligand Pharmaceuticals Inc Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$68.64 - $89.2 $455,495 - $591,931	6,636 New	6,636 $485,000
Q3 2023 Nov 14, 2023	BUY	$58.86 - $72.67 $372,760 - $460,219	6,333 New	6,333 $379,000
Q1 2023 May 15, 2023	SELL	$65.67 - $77.08 $4.29 Million - $5.03 Million	-65,280 Reduced 70.3%	27,583 $2.03 Million
Q4 2022 Feb 14, 2023	BUY	$61.72 - $96.74 $3.27 Million - $5.13 Million	52,980 Added 132.84%	92,863 $6.2 Million
Q2 2022 Aug 15, 2022	BUY	$74.52 - $117.06 $2.97 Million - $4.67 Million	39,883 New	39,883 $3.56 Million
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $1.12 Million - $1.46 Million	-8,776 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$102.33 - $144.73 $898,048 - $1.27 Million	8,776 New	8,776 $1.22 Million
Q1 2021 May 17, 2021	SELL	$99.52 - $215.83 $638,420 - $1.38 Million	-6,415 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$80.55 - $106.05 $516,728 - $680,310	6,415 New	6,415 $638,000
Q2 2020 Aug 13, 2020	SELL	$68.28 - $123.65 $346,725 - $627,894	-5,078 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $321,792 - $547,814	5,078 New	5,078 $369,000
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $2.61 Million - $3.63 Million	-30,205 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $2.79 Million - $3.36 Million	-25,956 Reduced 46.22%	30,205 $3.45 Million
Q1 2019 May 14, 2019	SELL	$105.93 - $142.47 $10.4 Million - $14 Million	-98,374 Reduced 63.66%	56,161 $7.06 Million
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $19.7 Million - $41.8 Million	153,440 Added 14012.79%	154,535 $21 Million
Q3 2018 Nov 14, 2018	SELL	$211.18 - $274.49 $964,459 - $1.25 Million	-4,567 Reduced 80.66%	1,095 $301,000
Q2 2018 Aug 14, 2018	BUY	$150.77 - $207.98 $853,659 - $1.18 Million	5,662 New	5,662 $1.17 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account